Cargando…
Impact of guideline-recommended versus non-guideline-recommended β-blocker and Doppler echocardiographic parameters on 1-year mortality in Thai ischemic cardiomyopathy patients: A prospective multicenter registry
BACKGROUND: Ischemic cardiomyopathy is a high-cost, resource-intensive public health burden that is associated with a 1-year mortality rate of about 16% in western population. Different in patient ethnicity and pattern of practice may impact the clinical outcome. We aim to determine 1-year mortality...
Autores principales: | Wongpraparut, Nattawut, Siwamogsatham, Sarawut, Thongsri, Tomorn, Ngamjanyaporn, Pornchai, Phrommintikul, Arintaya, Jirajarus, Kompoj, Tangcharoen, Tarinee, Bhumimuang, Kid, Kaewsuwanna, Pinij, Krittayaphong, Rungroj, Pongakasira, Rungtiwa, White, Harvey D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950985/ https://www.ncbi.nlm.nih.gov/pubmed/31918676 http://dx.doi.org/10.1186/s12872-019-01311-4 |
Ejemplares similares
-
Characteristics and Pattern of Calcified Nodule and/or Nodular Calcification Detected by Intravascular Ultrasound on the Device-Oriented Composite Endpoint (DoCE) in Patients with Heavily Calcified Lesions Who Underwent Rotational Atherectomy-Assisted Percutaneous Coronary Intervention
por: Pengchata, Ploy, et al.
Publicado: (2023) -
Rate of anticoagulant use, and factors associated with not prescribing anticoagulant in older Thai adults with non-valvular atrial fibrillation: A multicenter registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2019) -
Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease
por: Wongpraparut, Nattawut, et al.
Publicado: (2021) -
Long-term outcome of percutaneous transluminal renal angioplasty (PTRA) versus PTRA with stenting (PTRAS) in transplant renal artery stenosis
por: Wongpraparut, Nattawut, et al.
Publicado: (2021) -
Long-term outcome of renal nerve denervation (RDN) for resistant hypertension
por: Panchavinnin, Pariya, et al.
Publicado: (2022)